Skip to content

Treatment of ashmari (Urolithiasis) with Shwadamshtradi ghan vati

A comparative evaluation of antiurolithiatic and litholytic activity of shwadamshtradi ghana vati and potassium citrate tablet in the management of mutrashmari (urolithiasis): a randomized controlled clinical trialâ??

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/03/040730
Enrollment
136
Registered
2022-03-02
Start date
Unknown
Completion date
Unknown
Last updated
2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N22- Calculus of urinary tract in diseases classified elsewhere

Interventions

None listed

Sponsors

All India Institute of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Kidney stone size up to 15 mm 2. Ureteric Stone size up to 8 mm 3. Urinary Bladder Stone size up to 15 mm 4. Radiographic and /or USG evidence of the stone 5. Patients of Ashmari with controlled Hypertension & Diabetes Mellitus.

Exclusion criteria

Exclusion criteria: 1. Patients not willing for trial and follow up 2. Chronic Renal failure. 3. Gross Hydronephrosis. 4. Acute abdominal pain. 5. Cases which requires surgical intervention. 6. Severe Hematuria. 7. Kidney stone and Bladder Stone size more than 15 mm. 8. Ureteric stone Size more than 8 mm 9. Known cases of Malignancy, Tuberculosis. 10. Known cases of HIV (Human Immunodeficiency Virus), VDRL (Venereal Disease Research Laboratory) and Hepatitis-B positive.

Design outcomes

Primary

MeasureTime frame
Relieve in cardinal sign and symptoms of (Mutrashmari) Urolithiasis on the basis of USG reportTimepoint: The patients will be assessed on 30th day

Secondary

MeasureTime frame
restoration or maintenance normal renal function and renal parenchymal structureTimepoint: The patients will be assessed on 30th day

Countries

India

Contacts

Public ContactDr Vyasadeva Mahanta

All India Institute of Ayurveda

drvyasayu@yahoo.in7838957972

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026